Skip to main content

Table 2 The multifaceted roles of M6A-modified lncRNAs in human cancers

From: Novel insights into the multifaceted roles of m6A-modified LncRNAs in cancers: biological functions and therapeutic applications

Cancers

M6A-modified lncRNAs

Expression level

Functions

References

Colorectal cancer

XIST

Upregulated

Promote cell proliferation and metastasis

[107]

GAS5

Downregulated

Inhibit cancer progression

[108]

RP11

Upregulated

Promote metastasis

[110]

Gastric cancer

LINC01320

Upregulated

Promote cell proliferation

[92]

THAP7-AS1

Upregulated

Promote metastasis and cell proliferation

[113]

Esophageal squamous cell carcinoma

LINC00022

Upregulated

Promote cell proliferation

[116]

MALAT1

/

Promote metastasis

[90]

Hepatocellular carcinoma

lnc-CTHCC

Upregulated

Promote angiogenesis

[96]

LNCAROD

Upregulated

Promote glycolysis

[98]

LINC00958

Upregulated

Facilitate lipogenesis

[118]

Pancreatic cancer

DICER1-AS1

Downregulated

Inhibit glycolysis

[99]

WTAPP1

Upregulated

Promote cell proliferation

[122]

KCNK15-AS1

Downregulated

Inhibit cell proliferation

[123]

Nasopharyngeal carcinoma

ZFAS1

Upregulated

Regulate autophagy level

[127]

FAM225A

Upregulated

Promote cell proliferation

[128]

Lung cancer

MALAT1

Upregulated

Promote drug resistance and metastasis

[135]

ABHD11-AS1

Upregulated

Promote glycolysis

[136]

AC138035.1 et al.

/

/

[138]

SVIL-AS1

Downregulated

Inhibit cell proliferation

[142]

Prostate cancer

NEAT1-1

Upregulated

Promote metastasis

[88]

PCAT6

Upregulated

Promote metastasis

[89]

Cervical cancer

KCNMB2-AS1

Upregulated

Facilitate cancer progression

[144]

FOXD2-AS1

Upregulated

Facilitate cancer progression

[145]

Endometrial carcinoma

FENDDR

Downregulated

Inhibit cell proliferation

[93]

AL645568.1 et al.

/

/

[148]

Ovarian cancer

AC010894.3 et al.

/

/

[150]

AC008669.1 et al.

/

/

[151]

RHPN1-AS1

Upregulated

Promote cell proliferation and metastasis

[152]

Bladder cancer

AC020911.1 et al.

/

/

[155]

ZNRD1-AS1 et al.

/

/

[156]

Renal cell carcinoma

NEAT1

Downregulated

Inhibit cell proliferation

[158]

Lnc-LSG1

Downregulated

Inhibit metastasis

[159]

Thyroid cancer

HAGLR

Upregulated

Promote cell proliferation

[162]

MALAT1

Upregulated

Promote cell proliferation

[164, 165]

PSMG3-AS1 et al.

/

/

[167]

AC139795.2 et al.

/

/

[168]

Breast cancer

MIR210HG

Upregulated

Promote cell proliferation

[172]

LINC00958

Upregulated

Promote cell proliferation

[173]

Multiple myeloma

LOC606724

Upregulated

Promote drug resistance

[101]

SNHG1

Upregulated

Promote drug resistance

[101]

Lymphoma

TRERNA1

Upregulated

Promote cell proliferation

[177]

Leukemia

NEAT1

Downregulated

Promote apoptosis

[180]

AC025430.1 et al.

/

/

[182]

Osteosarcoma

ZBTB32 et al.

/

/

[186]

AP003119.2 et al.

/

/

[187]

FOXD2-AS1

Upregulated

Promote cell proliferation and metastasis

[188, 189]

PVT1

Upregulated

Promote cell proliferation

[190,191,192,193]

Skin cutaneous melanoma

RP11-775D22.3 et al.

/

/

[195]

Glioma

C6orf3 et al.

/

/

[198]

Glioblastoma

CASC9

Upregulated

Promote glycolysis

[200]

Head and neck squamous cell carcinoma

GRHL3-AS1 et al.

/

/

[203]

LNCAROD

Upregulated

Promote cell proliferation

[204]

Oral squamous cell carcinoma

AC079684.2 et al.

/

/

[206]

MALAT1

Upregulated

Promote cell proliferation

[207]

Laryngeal squamous cell carcinoma

KCNQ1OT1

Upregulated

Promote cell proliferation

[209]